Akershus University Hospital and the University of Oslo
Health conditions and target population approached by AHUS & UiO:
More than 3000 adults examined for suspected diagnosed with Obstructive Sleep Apnea and giving consent to participate in future research are available for inclusion. The majority of potential participants have received a treatment recommendation for using positive airway pressure (2 separate pilot studies). Studies have shown a strong association between Obstructive Sleep Apnea and cardiovascular disease including hypertension, atrial fibrillation, heart failure and pulmonary hypertension. Positive Airway Pressure therapy has been shown to significantly reduce cardiovascular risk, but adherence to the treatment is as low as 50-70%. Both mechanical and psychological factors have been related to treatment non-adherence. Experienced adherence challenges are leaks from masks when using Positive Airway Pressure therapy.
The University of Oslo (UiO) was founded in 1811 as the first university in Norway. Today it is the country’s largest public institution of research and higher education with 27 000 students and 7500 employees. UiO is the highest ranked institution of education and research in Norway - and have a strong track record of pioneering research and scientific discovery. Established in 1814, the Faculty of Medicine at the University of Oslo is the country's oldest and largest faculty of medicine responsibility for providing high standards of research and research-based education, hosting 9 master programs in addition to educating approx. one third of all medical students in Norway. The Faculty has an extensive EU project portfolio with more than 50 awarded projects and 7 ERC awardees.
Brief Partner Profile 700-bed primary teaching hospital for more than 560.000 persons. AHUS is one of the pioneers in Electronic Patient Records; and has participated in eHealth R&D activities as well as standardization, both nationally and internationally. Currently, AHUS is focusing on patient and consumer involvement, cross-level communication and technology deployment, on Artificial intelligence in Clinical work, on patient privacy and information security, and on standards for health informatics. In BEAMER, a special emphasis will be given to Adherence related to heart failure with preserved ejection fraction (HFpEF) and severe sleep apnoea.
Health conditions and target population approached by AHUS & UiO:
More than 3000 adults examined for suspected diagnosed with Obstructive Sleep Apnea and giving consent to participate in future research are available for inclusion. The majority of potential participants have received a treatment recommendation for using positive airway pressure (2 separate pilot studies). Studies have shown a strong association between Obstructive Sleep Apnea and cardiovascular disease including hypertension, atrial fibrillation, heart failure and pulmonary hypertension. Positive Airway Pressure therapy has been shown to significantly reduce cardiovascular risk, but adherence to the treatment is as low as 50-70%. Both mechanical and psychological factors have been related to treatment non-adherence. Experienced adherence challenges are leaks from masks when using Positive Airway Pressure therapy.
The University of Oslo (UiO) was founded in 1811 as the first university in Norway. Today it is the country’s largest public institution of research and higher education with 27 000 students and 7500 employees. UiO is the highest ranked institution of education and research in Norway - and have a strong track record of pioneering research and scientific discovery. Established in 1814, the Faculty of Medicine at the University of Oslo is the country's oldest and largest faculty of medicine responsibility for providing high standards of research and research-based education, hosting 9 master programs in addition to educating approx. one third of all medical students in Norway. The Faculty has an extensive EU project portfolio with more than 50 awarded projects and 7 ERC awardees.
Brief Partner Profile 700-bed primary teaching hospital for more than 560.000 persons. AHUS is one of the pioneers in Electronic Patient Records; and has participated in eHealth R&D activities as well as standardization, both nationally and internationally. Currently, AHUS is focusing on patient and consumer involvement, cross-level communication and technology deployment, on Artificial intelligence in Clinical work, on patient privacy and information security, and on standards for health informatics. In BEAMER, a special emphasis will be given to Adherence related to heart failure with preserved ejection fraction (HFpEF) and severe sleep apnoea.